iRhythm price target lowered to $85 from $100 at Citi

Citi lowered the firm’s price target on iRhythm to $85 from $100 and keeps a Neutral rating on the shares post the Q3 report. The firm says the company’s “conservative” guidance raise is offset by elevated expenses.